However, we also explored less well characterized KRAS landscapes such as in endometrial cancer, where KRAS G12V and G12D are predominant, as well as small bowel and appendiceal cancers, cholangiocarcinoma, and others. This evidence concerns the gene KRAS and cholangiocarcinoma.